Medtronic (NYSE:MDT) today announced data from the ALERT trial aimed at addressing health disparities in structural heart care.
Boston Scientific (NYSE:BSX) announced positive data from a randomized clinical trial evaluating its EKOS endovascular system.
Medtronic (NYSE:MDT) announced the launch of the EMBRACE trial of its Symplicity Spyral renal denervation (RDN) system.
This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...
Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Distalmotion’s Dexter surgical robotics system challenges the clinical and economic barriers that limit ambulatory surgical ...
Join us in Minneapolis to hear more from keynote speaker Lisa Earnhardt, at DeviceTalks Minnesota on May 4, 2026.
A Teleflex (NYSE:TFX) shareholder has written a letter to the company urging it to change its approach toward potential ...
Medtronic (NYSE:MDT) announced today that the FDA cleared its Stealth AXiS surgical robotic system for new indications.
According to multiple reports, Stryker (NYSE:SYK) has made significant strides in its restoration efforts following a recent ...
Novocure today announced positive findings from a study of its tumor treating fields (TTFields) in metastatic pancreatic ...
Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results